https://clarivate.com/life-sciences-healthcare/report/concmd0001-2019-biopharma-nonalcoholic-steatohepatitis-china-in-depth-2019/
Nonalcoholic Steatohepatitis | China In-Depth | 2019 | Clarivate
MARKET OUTLOOK NASH is a chronic disease that causes extensive and potentially fatal liver fibrosis; it is a leading cause of liver transplant. Significant...
china in depthnonalcoholic steatohepatitis2019clarivate
https://clarivate.com/life-sciences-healthcare/report/concon0002-2025-biopharma-non-small-cell-lung-cancer-china-in-depth-china-2025/
Non-Small-Cell Lung Cancer | China In-Depth | China | 2025 | Clarivate
Non-small-cell lung cancer (NSCLC) is the leading cause of cancer-related mortality in China. Treatment is based on biomarker status; patients with EGFR- and...
non small cell lung cancerchina in depth2025clarivate
https://clarivate.com/life-sciences-healthcare/report/concon0004-2021-biopharma-gastric-cancer-china-in-depth-china-2021/
Gastric Cancer | China In-Depth | China | 2021 | Clarivate
China has the highest incidence of gastroesophageal cancer globally, and therapeutic options are limited. Only five targeted agents are approved for...
china in depthgastric cancer2021clarivate
https://clarivate.com/life-sciences-healthcare/report/concim0001-2019-biopharma-rheumatoid-arthritis-china-in-depth-china-2019/
Rheumatoid Arthritis | China In-Depth | China | 2019 | Clarivate
MARKET OUTLOOK Rheumatoid arthritis (RA) is a chronic and progressive autoimmune disease that primarily affects the joints. China has globally the highest...
china in depthrheumatoid arthritis2019clarivate
https://clarivate.com/life-sciences-healthcare/report/concon0007-2019-biopharma-bladder-cancer-china-in-depth-china-2019/
Bladder Cancer | China In-Depth | China | 2019 | Clarivate
Bladder cancer is one of the most commonly diagnosed cancers and a substantial cause of cancer-related deaths in China. The bladder cancer market is set to...
china in depthbladder cancer2019clarivate
https://clarivate.com/life-sciences-healthcare/report/concim0001-2022-biopharma-rheumatoid-arthritis-china-in-depth-china-2022/
Rheumatoid Arthritis | China In-Depth | China | 2022 | Clarivate
Rheumatoid arthritis (RA) is a chronic and progressive autoimmune disease that primarily affects the joints. China has the highest number of RA patients in the...
china in depthrheumatoid arthritis2022clarivate